Expression of SKP2 protein in non-small cell lung carcinoma

Chinese Journal of Cancer Research

Volumn 19, Issue 3, 2007, Pages 195-200

  Yang, Chun Lu ^a   Zhao, Jun ^b   Zhao, Su Ying ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Shenyang Municipal Thoracic Hospital   (China)

^c Shenyang No7 People's Hospital   (China)

Author keywords

Cell cycle; Immunohistochemistry; NSCLC; SKP2 protein; Tissue chip

Indexed keywords

S PHASE KINASE ASSOCIATED PROTEIN 2;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SMOKING; STAINING; SURVIVAL RATE; SURVIVAL TIME;

EID: 35048844712     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-007-0195-1     Document Type: Article

References (15)

1. Falleni M, Pellegrini C, Marchetti A, et al. Survivin gene expression in early-stage non-small cell lung cancer [J]. J Pathol 2003; 200:620-6.
2. Latres E, Chiarle R, Schulm BA, et al. Role of the F-box protein SKP2 in lymphomagenesis [J]. Proc Natl Acad Sci USA 2001; 98:2515-20.
3. Yokoi S, Yasui K, Lizasa T, et al. Down-regulation of SKP2 induces apoptosis in lung-cancer cells [J]. Cancer Sci 2003; 94:344-9.
4. Zhu CQ, Blackhall FH, Pintilie M, et al. Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker [J]. Clin Cancer Res 2004; 10:1984-91.
5. Yokoi S, Yasui K, Mori M, et al. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes [J]. Am J Pathol 2004; 165:175-80.
6. Goto A, Niki T, Moriyama S, et al. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma [J]. Pathol Int 2004; 54:675-81.
7. Sumimoto H, Yamagata S, Shimizu A, et al. Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference [J]. Gene Ther 2005; 12:95-100.
8. Osoegawa A, Yoshino I, Tanaka S, et al. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer [J]. J Clin Oncol 2004; 22:4165-73.
9. Jiang F, Yin Z, Caraway NP, et al. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia 2004; 6:623-35.
10. Ishii T, Matsuse T, Masuda M, et al. The effects of S-phase kinase-associated protein 2 (SKP2) on cell cycle status, viability, and chemoresistance in A549 lung adenocarcinoma cells [J]. Exp Lung Res 2004; 30:687-703.
11. Jiang F, Caraway NP, Li R, et al. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells [J]. Oncogene 2005; 24:3409-18.
12. Takanami I. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer [J]. Oncol Rep 2005; 13:727-31.
13. Lee SH, McCormick F. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells [J]. J Mol Med 2005; 83:296-307.
14. Carrano AC, Eytan E, Hershko A, et al. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J]. Nat Cell Biol 1999; 1:193-9.
15. Ezoe S, Matsumura I, Nakata S, et al. GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21 (WAF1) and p27 (Kip1) proteins [J]. Blood 2002: 100:3512-20.